Clene Inc (CLNN) Peer Comparison

$4.21

$-0.26 (-5.82%)

As on 28-Aug-2026 13:39EDT

Market cap

$56 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

7.8

Div. Yield

0 %

Edit

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	56	17,326	16,614	13,400	12,305
Revenue ($ Mln)	0	2,782	1,054	2,436	670
Net Profit ($ Mln)	-39.52	491.50	755.85	860.62	-319.95
Net Margin (%)	-20,059.90	17.67	71.69	35.33	-47.79
RoE (%)	--	110.09	--	42.98	-71.14
Price to Earnings	--	36.49	19.38	17.01	--
Price-To-Book	7.83	39.43	10.05	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	0.20	2,782.29	1,054.37	2,435.92	669.50
Cost of Revenue	0.41	1,982.07	103.47	85.67	19.14
Gross Profit	0.16	760.62	588.53	2,236.43	829.45
Operating Expenses	20.08	216.81	841.45	1,378.74	895.93
Operating Profit (EBIT)	-20.30	583.40	109.45	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-39.52	598.92	101.11	1,035.47	-252.08
Provision for Tax	0.00	107.42	-654.74	174.84	20.05
Profit after Tax (Net Income)	-39.52	491.50	755.85	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	-24.78	433.86	1,435.90	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	42.97	187.89	384.48	288.55	1,362.63
Current Liabilities	4.85	1,435.43	464.70	361.93	283.35
Total Liabilities	18.13	1,975.47	1,302.02	2,844.42	1,385.30

Assets ($ Mln)

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	8.13	1,006.90	895.24	1,243.41	440.60
Current Assets	14.91	1,050.29	1,389.84	1,250.82	1,671.41
Total Assets	18.13	1,975.47	1,302.02	2,844.42	1,385.30
Total Debt*	22.34	120.10	449.89	165.93	864.07
Net Current Assets	0.00	-385.14	0.00	888.90	1,388.07

Cashflow ($ Mln)

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	-18.55	713.22	51.77	884.27	179.55
Cash Flow from Investing Activities	-0.04	-31.14	-8.15	350.44	-129.29
Cash from Financing Activities	11.52	-860.39	34.89	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	-325.80	53.56	-30.01	32.82	-0.17
ROE (%)	197.91	110.09	163.18	42.98	-71.14
ROA (%)	-116.82	15.64	26.53	29.32	-16.12
EBIT Margin (%)	-14,850.25	21.13	5.73	31.04	-0.77
Net Margin (%)	-20,059.90	17.67	71.69	35.33	-47.79
Cash Profit Margin (%)	-0.02	0.00	0.00	0.00	0.00

Growth Ratios

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-31.12	24.67	114.85	9.23	12.22
EBIT Growth (%)	-8.84	18.70	136.39	-3.99	93.17
Net Profit Growth (%)	-33.03	17.50	378.76	42.89	-115.58
EPS Growth (%)	11.47	26.84	353.27	50.42	-73.87
Book Value Growth (%)	-122.88	164.02	816.12	-0.70	-13.57

Valuation Ratios

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	-2.21	36.06	-59.76	15.79	-2,869.63
Price / Book Value	-3.29	35.44	-80.42	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	-3.38	28.08	-121.54	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	-0.05	0.00	0.05	0.00	0.09
Current Ratio	3.07	0.73	2.99	3.46	5.90
Quick Ratio	3.07	0.73	2.32	3.38	5.90
Interest Coverage	-12.72	--	1.62	--	-1.72

Operating Efficiency Ratios

	Clene Inc (CLNN)	Medpace Holdings (MEDP)	Ascendis Pharma A/S - ADR	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	600.51	15.88	21.25	13.74	1.28
Asset Turnover	0.01	0.89	0.37	0.83	0.34
Receivable days	895.78	50.42	85.52	43.48	1.50
Inventory Days	445.94	--	1,056.70	96.17	--
Payable days	9,054.80	6.26	331.01	147.97	221.81
Cash Conversion Cycle	-7,713.08	--	811.21	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly